financetom
Business
financetom
/
Business
/
ASML says its revenue to grow to between $46 billion and $63 billion by 2030
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ASML says its revenue to grow to between $46 billion and $63 billion by 2030
Nov 14, 2024 12:04 AM

AMSTERDAM (Reuters) - Computer chip equipment maker ASML said on Thursday it expects its sales to grow to between 44 billion euros and 60 billion ($46.4 billion-$63.3 billion) by 2030, suggesting an average annual increase of 8%-14%, driven by strong demand for its most advanced tools.

The guidance came in a statement ahead of the company's biannual investor day at its headquarters in Veldhoven, Netherlands.

"We expect that our ability to scale EUV technology into the next decade ... positions ASML well to contribute to, and leverage the artificial intelligence opportunity, and (will allow) ASML to deliver significant revenue and profitability growth," CEO Christophe Fouquet said in a statement.

The revenue forecast and guidance for gross margins of between 56%-60% are unchanged from the company's previous long- term guidance issued in 2022.

The guidance follows third quarter earnings in October that missed analysts' expectations by the most in years, as customers such as Intel and Samsung delayed orders for equipment amid weakness in chip markets other than AI.

($1 = 0.9478 euros)

(Reporting by Toby Sterling; Editing by Muralikumar Anantharaman)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vertex Pharmaceuticals Q3 Non-GAAP EPS, Revenue Increase
Vertex Pharmaceuticals Q3 Non-GAAP EPS, Revenue Increase
Nov 3, 2025
04:13 PM EST, 11/03/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) reported fiscal Q3 non-GAAP net income late Monday of $4.80 per diluted share, up from $4.38 a year earlier. Analysts polled by FactSet expected earnings of $4.58. Revenue in the three months ended Sept. 30 rose to $3.08 billion from $2.77 billion a year earlier. Analysts expected $3.06...
Addus Homecare Q3 revenue up on personal care business
Addus Homecare Q3 revenue up on personal care business
Nov 3, 2025
Overview * Addus Q3 net service revenues up 25% yr/yr to $362.3 mln * Adjusted EPS for Q3 beats analyst expectations * Adjusted EBITDA for Q3 beats analyst expectations * Company completed Del Cielo acquisition on Oct 1, expanding Texas operations Outlook * Company anticipates positive impact from recent Texas rate increase * Addus expects continued growth in hospice care...
Gallium nitride chipmaker Navitas' Q3 revenue beats expectations
Gallium nitride chipmaker Navitas' Q3 revenue beats expectations
Nov 3, 2025
Overview * Navitas Q3 2025 revenue beats analyst expectations despite declining yr/yr * Company reports GAAP loss from operations improves compared to Q3 2024 * Navitas pivots to high-power markets, collaborating with NVIDIA on AI data centers Outlook * Navitas expects Q4 2025 net revenues of $7.0 mln, plus or minus $0.25 mln * Company anticipates Q4 2025 non-GAAP gross...
Gladstone Commercial Q3 revenue beats estimates on strong rent collection
Gladstone Commercial Q3 revenue beats estimates on strong rent collection
Nov 3, 2025
Overview * Gladstone Q3 operating revenue grows 3.3%, beating analyst expectations * Net income for Q3 beats analyst estimates despite decline from prior quarter * Company acquired six-facility portfolio and sold non-core property Outlook * Gladstone Commercial ( GOOD ) did not provide specific future guidance in the statement Result Drivers * PROPERTY ACQUISITIONS - Co acquired a six-facility portfolio,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved